Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Defining An Optimal Therapeutic Range for Busulfan (Bu) Administered with Pre-and Post-Transplant Cyclophosphamide (Cy) In HLA-Matched Related and Unrelated Bone Marrow Transplantation (BMT).

Lindsey R Lombardi, PharmD, Marianna Zahurak, M.S., Nadira Durakovic, MD, PhD, Jeanne Kowalski, PhD, Richard J. Jones, MD, Leo Luznik, MD

Blood (2010) 116 (21): 3474.

https://doi.org/10.1182/blood.V116.21.3474.3474

Published: 2010

Journal Articles

Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand disease

PM Mannucci, A Lattuada, G Castaman, R Lombardi, ML Colibretti, N Ciavarella, F Rodeghiero

Blood (1989) 74 (7): 2433–2436.

https://doi.org/10.1182/blood.V74.7.2433.2433

Published: 1989

Journal Articles

Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome

PM Mannucci, R Lombardi, A Lattuada, P Ruggenenti, GL Vigano, T Barbui, G Remuzzi

Blood (1989) 74 (3): 978–983.

https://doi.org/10.1182/blood.V74.3.978.978

Published: 1989

Journal Articles

Supranormal von Willebrand factor multimers in scleroderma

PM Mannucci, R Lombardi, A Lattuada, E Perticucci, R Valsecchi, G Remuzzi

Blood (1989) 73 (6): 1586–1591.

https://doi.org/10.1182/blood.V73.6.1586.1586

Published: 1989

Journal Articles

Adhesive properties of the carbohydrate-modified von Willebrand factor (CHO-vWF)

AB Federici, C De Romeuf, PG De Groot, B Samor, R Lombardi, P D'Alessio, C Mazurier, PM Mannucci, JJ Sixma

Blood (1988) 71 (4): 947–952.

https://doi.org/10.1182/blood.V71.4.947.947

Published: 1988

Journal Articles

von Willebrand disease "Vicenza" with larger-than-normal (supranormal) von Willebrand factor multimers

PM Mannucci, R Lombardi, G Castaman, JA Dent, A Lattuada, F Rodeghiero, TS Zimmerman

Blood (1988) 71 (1): 65–70.

https://doi.org/10.1182/blood.V71.1.65.65

Published: 1988

Journal Articles

A new variant of type II von Willebrand disease with aberrant multimeric structure of plasma but not platelet von Willebrand factor (type IIF)

PM Mannucci, R Lombardi, AB Federici, JA Dent, TS Zimmerman, ZM Ruggeri

Blood (1986) 68 (1): 269–274.

https://doi.org/10.1182/blood.V68.1.269.269

Published: 1986

Journal Articles

Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor

PM Mannucci, R Lombardi, R Bader, L Vianello, AB Federici, S Solinas, MG Mazzucconi, G Mariani

Blood (1985) 66 (4): 796–802.

https://doi.org/10.1182/blood.V66.4.796.796

Published: 1985

Journal Articles

Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies

PM Mannucci, R Lombardi, R Bader, MH Horellou, G Finazzi, C Besana, J Conard, M Samama

Blood (1984) 64 (3): 614–621.

https://doi.org/10.1182/blood.V64.3.614.614

Published: 1984

Journal Articles

A variant of von Willebrand's disease characterized by recessive inheritance and missing triplet structure of von Willebrand factor multimers

PM Mannucci, R Lombardi, FI Pareti, S Solinas, MG Mazzucconi, G Mariani

Blood (1983) 62 (5): 1000–1005.

https://doi.org/10.1182/blood.V62.5.1000.1000

Published: 1983

Journal Articles

Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor

ZM Ruggeri, R Lombardi, L Gatti, R Bader, C Valsecchi, TS Zimmerman

Blood (1982) 60 (6): 1453–1456.

https://doi.org/10.1182/blood.V60.6.1453.1453

Published: 1982

Journal Articles

Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes

ZM Ruggeri, PM Mannucci, R Lombardi, AB Federici, TS Zimmerman

Blood (1982) 59 (6): 1272–1278.

https://doi.org/10.1182/blood.V59.6.1272.1272

Published: 1982

NARROW

Defining An Optimal Therapeutic Range for Busulfan (Bu) Administered with Pre-and Post-Transplant Cyclophosphamide (Cy) In HLA-Matched Related and Unrelated Bone Marrow Transplantation (BMT).

Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand disease

Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome

Supranormal von Willebrand factor multimers in scleroderma

Adhesive properties of the carbohydrate-modified von Willebrand factor (CHO-vWF)

von Willebrand disease "Vicenza" with larger-than-normal (supranormal) von Willebrand factor multimers

A new variant of type II von Willebrand disease with aberrant multimeric structure of plasma but not platelet von Willebrand factor (type IIF)

Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor

Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies

A variant of von Willebrand's disease characterized by recessive inheritance and missing triplet structure of von Willebrand factor multimers

Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor

Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only